As treatment strategies for patients with ALK‐rearrangement non‐small‐cell lung cancer (NSCLC) are constantly evolving and given the continuing concerns regarding ALK‐TKI‐induced pneumonitis, we aimed to update this previous meta‐analysis. This evidence concerns the gene ALK and pneumonitis.